First participant in IGF-1 clinical trial

Rebecca Singer is the first participant in the Seaver Autism Center clinical trial of insulin-like growth factor-1 in children with Phelan-McDermid Syndrome. If this trial shows positive results, the eventual goal is to translate it to ASD more broadly. To read about Rebecca’s participation in this study, click here.

To view all posts, click here.

This entry was posted in News. Bookmark the permalink.